Evaxion Biotech AS (EVAX) is an advanced clinical-stage biopharmaceutical company based in Hørsholm, Denmark, specializing in the application of artificial intelligence to transform immunotherapy development. The company is dedicated to addressing critical unmet medical needs in oncology, bacterial diseases, and viral infections through its proprietary platform, which facilitates the discovery of innovative therapeutic candidates. With a diverse and promising pipeline of treatments, Evaxion is strategically positioned to enhance patient care and lead a shift in therapeutic approaches within the biotechnology landscape. Show more

Location: DR. NEERGAARDS VEJ, HORSHOLM, DENMARK, 2970, Horsholm, 2970, USA | Website: https://evaxion.ai | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

26.52M

52 Wk Range

$1.20 - $12.15

Previous Close

$3.40

Open

$3.38

Volume

76,707

Day Range

$3.14 - $3.38

Enterprise Value

1.001B

Cash

10.57M

Avg Qtr Burn

N/A

Insider Ownership

18.39%

Institutional Own.

5.89%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
EVX-01 + pembrolizumab Details Melanoma	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EVX-02 Details Melanoma	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EVX-04 (Cancer Vaccine) Details Acute Myeloid Leukemia	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.